Vridapa-M 5/500 Tablet ER

Short Description

Vridapa-M 5/500 Tablet ER is a combination of two medicines used to treat type 2 diabetes mellitus, controlling high blood sugar levels and reducing the risk of heart disease.

Dosage Form

Tablet ER

Introduction

Vridapa-M 5/500 Tablet ER is a combination of two antidiabetic medicines: Dapagliflozin and Metformin. It helps control the high blood sugar levels seen in diabetes, reducing the chances of serious complications of diabetes and also helps prevent heart disease.

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Vridapa-M 5/500 Tablet ER is to be taken with food.

Vridapa-M 5/500 Tablet ER is a combination of two antidiabetic medicines: Dapagliflozin and Metformin. Dapagliflozin works by removing excess sugar (glucose) from your body through urine. Metformin works by lowering sugar production in the liver, delaying glucose absorption from intestines, and increasing the body's sensitivity to insulin. Together, they provide better control of blood sugar.

You should continue to exercise regularly, eat a healthy diet, and take your other diabetes medicines (if prescribed) along with Vridapa-M 5/500 Tablet ER. Take it with food to lower your chance of having an upset stomach. Vridapa-M 5/500 Tablet ER can cause urinary tract infection. Make sure to drink plenty of fluids and practice good genital hygiene. It may cause your body to lose too much fluid (dehydration) or you to urinate more often. Drink plenty of water and stay hydrated. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Always carry some sugary food or fruit juice with you in case you experience hypoglycemia symptoms.